Specialized Medical Company (TADAWUL:4019)

Market Cap	3.33B -32.1%
Revenue (ttm)	1.57B +7.2%
Net Income	277.95M +84.0%
EPS	1.11 +84.0%
Shares Out	250.00M
PE Ratio	11.96
Forward PE	12.99
Dividend	0.32 (2.41%)
Ex-Dividend Date	May 18, 2026

Volume	1,540,797
Open	13.70
Previous Close	13.72
Day's Range	13.02 - 13.71
52-Week Range	13.00 - 21.49
Beta	n/a
Analysts	Buy
Price Target	22.67 (+70.45%)
Est. Earnings	Nov 9, 2026

About TADAWUL:4019

Specialized Medical Company owns and operates hospitals, clinics, and medical centers in the Kingdom of Saudi Arabia. The company operates through Medical Services, and Pharmacies and Others segments. It provides diagnostic and therapeutic services for emergency medicine, cardiology, internal and family medicine, and pediatrics; and ancillary services, such as lab histopathology, diagnostic radiology and nuclear medicine, anesthesiology, pharmacy, and physiotherapy rehab. The company also operates surgical units comprising operating room and re...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1994
• Employees: 3,353
• Stock Exchange: Saudi Stock Exchange
• Ticker Symbol: 4019

Financial Performance

In 2025, TADAWUL:4019's revenue was 1.54 billion, an increase of 7.00% compared to the previous year's 1.44 billion. Earnings were 266.23 million, an increase of 43.74%.

Analyst Summary

According to 3 analysts, the average rating for 4019 stock is "Buy." The 12-month stock price target is SAR 22.67, which is an increase of 70.45% from the latest price.

Price Target

SAR 22.67

(70.45% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 16, 2026

Data Sources Report a data error